Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 83 | |
2 mg | In stock | $ 149 | |
4 mg | In stock | $ 211 | |
10 mg | In stock | $ 397 | |
20 mg | In stock | $ 635 |
Description | Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively. |
Targets&IC50 | CECR2:0.017 μM, BRD4:0.29 μM, BRD2:0.41 μM, BRD9:0.122 μM |
In vitro | Bromosporine (1 μM) accelerates FRAP recovery of BRD4 and CREBBP, while shows no activities against TIF1α, BAZ2A, and SMARCA2 even at 10 μM. Bromosporine (18 μM) has moderate cytotoxicity in HeLa cells. |
CAS No. | 1619994-69-2 |
Chemical Formula | C17H20N6O4S |
Molecular Weight | 404.45 |
Solubility | DMSO: 51.7 mg/mL |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom